About this trial
This trial was a 1:1 (active:placebo) randomized, double-blind, placebo-controlled trial to evaluate the safety and efficacy of prednisone and aspirin for the in vitro fertilization and embryo transfer outcome among patients with thyroid autoimmunity.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
TPOAb>34IU/ml and/or TgAb>115IU/ml
≥5 follicles with average diameter lager than 14 mm at trigger day
≥5 oocytes retrieved
for frozen embryo transfer, at least 2 cleavage stage embryos, among which at least one morphologically good quality embryo, or at least 1 morphologically good quality embryo in blastocyst stage
Disqualifiers
hyperthyroidism
intrauterine adhesion
with endometrium thickness less than 6mm
uterine malformation
Trial design
Parallel
Treatments tested in this trial
Prednisone and Aspirin
Drugprednisone 10 mg and aspirin 75-100mg per day per os
Placebo
Drugplacebo 2 starch tablets per day per os
Treatment groups
Trial outcomes
Primary outcomes
clinical pregnancy rate
ultrasound visualization of the gestational sac
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead sponsor
Ningbo Women & Children's Hospital
Collaborator
Jinhua People's Hospital
Collaborator
Jiaxing Maternity and Child Health Care Hospital
Collaborator
This trial is not recruiting at the moment. You can still explore other options: